院前腺苷、利多卡因与镁在猪模型长时间失血性休克中生存率劣于战术战伤救治复苏
该研究为猪随机对照实验,比较院前腺苷、利多卡因与镁(ALM)不同剂量方案与战术战伤救治(TCCC)复苏在长时间失血性休克中的效果。动物经压力控制性失血至平均动脉压30 mm Hg,T=0给药,模拟院前救治120分钟后开始血制品复苏。结果显示TCCC生存率优于所有其他组,ALM组与载体对照组平均动脉压和收缩压低于TCCC;ALM组除载体对照组外乳酸水平相似且碱缺失纠正,肾肝功能各组相当;TCCC组较基线出现显著低凝。作者结论:本研究中ALM给药方案在长时间失血性休克生存方面劣于现行含羟乙基淀粉的TCCC复苏,ALM不适合作为当前TCCC复苏的低容量替代,但ALM组凝血病较TCCC轻,值得未来研究作为治疗辅助。
要点
- 猪长时间失血性休克模型中,TCCC复苏生存率优于所有ALM方案及载体对照组。
- ALM组和载体对照组平均动脉压与收缩压均低于TCCC组。
- 除载体对照组外,ALM各组院前复苏后乳酸水平与TCCC相似,碱缺失得到纠正。
- 各组肾功能和肝功能相当;TCCC组较基线出现显著低凝。
- 作者认为ALM不适合作为当前TCCC复苏的低容量替代,但凝血病较轻值得未来研究作为辅助治疗。
适用人群与场景
- 猪长时间失血性休克模型,经压力控制性失血至平均动脉压30 mm Hg。
处置流程与药物剂量
- 随机分组:TCCC、2 mL·kg载体对照、2 mL·kg ALM+滴注、4 mL·kg ALM+滴注、4 mL·kg ALM+延迟滴注0.5 mL·kg·h、4 mL/kg载体对照、4 mL·kg ALM输注15分钟+延迟滴注3 mL·kg·h。
- T=0给予研究药物,模拟院前救治120分钟后(T=120)开始血制品复苏。
研究设计与关键结果
- 研究类型:猪随机对照实验;样本量原文未报告。
- 主要结果:TCCC生存率优于所有其他组;载体对照与ALM组平均动脉压和收缩压低于TCCC组。
- 除载体对照组外,ALM各组乳酸水平相似,院前复苏后碱缺失纠正;肾功能和肝功能各组相当。
- TCCC组较基线出现显著低凝;ALM组生存者收缩压和平均动脉压较低,但凝血病较TCCC轻。
证据类型、等级与局限
- 证据类型:动物随机对照实验。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,本研究中ALM给药方案在长时间失血性休克生存方面劣于现行含羟乙基淀粉的TCCC复苏,不适合作为当前TCCC复苏的低容量替代。
- 作者认为,ALM组凝血病较TCCC轻,值得未来研究作为治疗辅助。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Adenosine, lidocaine, and magnesium (ALM) is a cardioplegic agent shown to improve survival by improving cardiac function, tissue perfusion, and coagulopathy in animal models of shock. We hypothesized prehospital ALM treatment in hemorrhagic shock would improve survival compared to current Tactical Combat Casualty Care (TCCC) resuscitation beyond the golden hour.
METHODS: Swine were randomized to: (1) TCCC, (2) 2 mL·kg vehicle control (VC), (3) 2 mL·kg ALM + drip, (4) 4 mL·kg ALM + drip, 5) 4 mL·kg ALM + delayed drip at 0.5 mL·kg·h, 6) 4 mL/kg VC, 7) 4 mL·kg ALM for 15 minutes + delayed drip at 3 mL·kg·h. Animals underwent pressure controlled hemorrhage to mean arterial pressure (MAP) of 30 mm Hg (S = 0). Treatment was administered at T = 0. After 120 minutes of simulated prehospital care (T = 120) blood product resuscitation commenced. Physiologic variables were recorded and laboratories were drawn at specified time points.
RESULTS: Tactical Combat Casualty Care demonstrated superior survival to all other agents. The VC and ALM groups had lower MAPs and systolic blood pressures compared with TCCC. Except for the VC groups, lactate levels remained similar with correction of base deficit after prehospital resuscitation in all groups. Kidney function and liver function remained comparable across all groups. Compared with baseline values, TCCC demonstrated significant hypocoagulability.
CONCLUSION: Adenosine, lidocaine, and magnesium, as administered in this study, are inferior to current Hextend-based resuscitation for survival from prolonged hemorrhagic shock in this model. In survivors, ALM groups had lower systolic blood pressures and MAPs, but provided a protective effect on coagulopathy as compared to TCCC. Adenosine, lidocaine, and magnesium do not appear to be a suitable low volume replacement to current TCCC resuscitation. The reduced coagulopathy compared to TCCC warrants future studies of ALM, perhaps as a therapeutic adjunct.
参考来源
- How RA, Glaser JJ, Schaub LJ, et al. Prehospital adenosine, lidocaine, and magnesium has inferior survival compared with tactical combat casualty care resuscitation in a porcine model of prolonged hemorrhagic shock. J Trauma Acute Care Surg. 2019. PMID: 30985476. doi:10.1097/TA.0000000000002308
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。